Enzymotec Ltd. announced the appointment of Tamar Howson to its Board of Directors, effective July 29, 2015. Ms. Howson brings with her a wealth of business development experience from the biotechnology and pharmaceutical industries, which will be an asset to Board as well as to the entire company. The company believe that Ms. Howson's industry expertise will complement the company's strategic growth initiatives.

Tamar Howson has served as a corporate business development and strategy consultant to biopharmaceutical companies since 2011. From 2009 to 2011, she worked for JSB-Partners. From 2007 to 2008, Ms. Howson served as Executive Vice President, Corporate Business Development at Lexicon Pharmaceuticals.